how does retatrutide burn fat works: mechanism of action and onset explained Retatrutide for Visceral Fat Loss

Using PET-CT imaging after intravenous administration of 18 F-FDG to T2DM patients treated with metformin, researchers showed that the amount of glucose entering the gastrointestinal system from the circulation was increased, which contributed to the drugs glucose-lowering effect and improved glycemic control (Koffert et al., 2017

Patients on Wegovy HD lost an average of 20.7% of body weight over 72 weeks, compared with 17.5% on Wegovy 2.4 mg

If approved, patients will receive a letter in the mail

Please consult a qualified health practitioner if you have a pre-existing health condition or are currently taking medication

Sattar N, Neeland IJ, Leinhard OD, et al